Timothy Liesching
4 Papers
Timothy Liesching is an academic researcher. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & DLCO. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
Jamie L. Todd,Megan L. Neely,Robert Overton,Katey Durham,Mridu Gulati,Howard J. Huang,Jesse Roman,L. Kristin Newby,Kevin R. Flaherty,Richard Vinisko,Yi Liu,Janine Roy,Ramona Schmid,Benjamin Strobel,Christian Hesslinger,Thomas Leonard,Imre Noth,John A. Belperio,Scott M. Palmer,Wael Asi,Albert Baker,Scott Beegle,Rany Condos,Francis Cordova,Daniel A. Culver,Joao A. de Andrade,Daniel F. Dilling,Marilyn K. Glassberg,Kalpalatha Guntupalli,Nishant Gupta,Amy Hajari Case,David Hotchkin,Tristan J. Huie,Robert J. Kaner,Hyun J Kim,Maryl Kreider,Lisa Lancaster,Joseph A. Lasky,David J. Lederer,Doug Lee,Timothy Liesching,Randolph J. Lipchik,Jason Lobo,Yolanda Mageto,Prema Menon,Lake Morrison,Andrew Namen,Justin M. Oldham,Rishi Raj,Murali Ramaswamy,Tonya D. Russell,Paul Sachs,Zeenat Safdar,Barry Sigal,Leann Silhan,Mary E. Strek,Sally Suliman,Jeremy Tabak,Rajat Walia,Timothy P.M. Whelan +59 more
TL;DR: Patients with IPF have a distinct circulating proteome and can be distinguished using a nine-protein profile that may represent biomarker candidates and implicate pathways for further investigation.
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: Insights from the IPF-PRO Registry
Laurie D. Snyder,Megan L. Neely,Anne S. Hellkamp,Emily C. O'Brien,Joao Alberto de Andrade,Craig S Conoscenti,Thomas Leonard,Shaun Bender,Mridu Gulati,Daniel A. Culver,Robert J. Kaner,Scott M. Palmer,Hyun J Kim,Wael Asi,Albert Baker,Scott Beegle,John A. Belperio,Rany Condos,Francis Cordova,Joao A. de Andrade,Daniel F. Dilling,Kevin R. Flaherty,Marilyn K. Glassberg,Kalpalatha K. Guntupalli,Nishant Gupta,Amy Hajari Case,David Hotchkin,Tristan J. Huie,Maryl Kreider,Lisa Lancaster,Joseph A. Lasky,David J. Lederer,Doug Lee,Timothy Liesching,Randolph J. Lipchik,Jason Lobo,Yolanda Mageto,Prema Menon,Lake Morrison,Andrew Namen,Justin M. Oldham,Rishi Raj,Murali Ramaswamy,Tonya D. Russell,Paul Sachs,Zeenat Safdar,Barry Sigal,Leann Silhan,Mary E. Strek,Sally Suliman,Jeremy Tabak,Rajat Walia,Timothy P.M. Whelan,Julie Fleming,Wendy Morris +54 more
TL;DR: In an observational US registry of patients with IPF, oxygen use at rest, lower FVC % predicted, and lower DLco % predicted were associated with risk of death or lung transplant.
Hospitalizations in patients with idiopathic pulmonary fibrosis.
Hyun J Kim,Laurie D. Snyder,Laurie D. Snyder,Ayodeji Adegunsoye,Megan L. Neely,Megan L. Neely,Shaun Bender,Eric S. White,Craig S Conoscenti,Mary E. Strek,Albert Baker,Scott Beegle,John A. Belperio,Rany Condos,Francis Cordova,Daniel A. Culver,Daniel F. Dilling,John Fitzgerald,Leann Silhan,Kevin R. Flaherty,Kevin F. Gibson,Mridu Gulati,Kalpalatha K. Guntupalli,Nishant Gupta,Amy Hajari Case,David Hotchkin,Tristan J. Huie,Robert J. Kaner,Lisa Lancaster,Mark P. Steele,Joseph A. Lasky,Doug Lee,Timothy Liesching,Randolph J. Lipchik,Jason Lobo,Tracy Luckhardt,Joao A. Andrade,Yolanda Mageto,Howard J. Huang,Prema Menon,Lake Morrison,Andrew Namen,Justin M. Oldham,Tessy Paul,David Zhang,Anna J. Podolanczuk,David J. Lederer,Nina Patel,Mary K. Porteous,Maryl Kreider,Rishi Raj,Paul Mohabir,Murali Ramaswamy,Tonya D. Russell,Paul Sachs,Zeenat Safdar,Shirin Shafazand,Marilyn K. Glassberg,Ather Siddiqi,Wael Asi,Barry Sigal,Imre Noth,Sally Suliman,Jesse Roman,Jeremy Tabak,Rajat Walia,Timothy P.M. Whelan +66 more
TL;DR: In this paper, the authors investigated the impact of hospitalizations on outcomes in patients with idiopathic pulmonary fibrosis (IPF) using Cox regression models and found that the risk of mortality associated with a respiratory hospitalization or a hospitalization with ventilatory support was high.
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Jamie L. Todd,Richard Vinisko,Yi Liu,Megan L. Neely,Robert Overton,Kevin R. Flaherty,Imre Noth,L. Kristin Newby,Joseph A. Lasky,Mitchell A. Olman,Christian Hesslinger,Thomas Leonard,Scott M. Palmer,John A. Belperio,Wael Asi,Albert Baker,Scott Beegle,Rany Condos,Francis Cordova,Daniel A. Culver,Tracey Luckhardt,Daniel F. Dilling,Marilyn K. Glassberg,Mridu Gulati,Kalpalatha K. Guntupalli,Nishant Gupta,David Hotchkin,Tristan J. Huie,Robert J. Kaner,Hyun J Kim,Maryl Kreider,Lisa Lancaster,David J. Lederer,Doug Lee,Timothy Liesching,Randolph J. Lipchik,Jason Lobo,Yolanda Mageto,Prema Menon,Lake Morrison,Andrew Namen,Justin M. Oldham,Rishi Raj,Murali Ramaswamy,Tonya D. Russell,Paul Sachs,Zeenat Safdar,Barry Sigal,Leann Silhan,Mary E. Strek,Sally Suliman,Jeremy Tabak,Rajat Walia,Timothy P.M. Whelan +53 more
TL;DR: Circulating MMPs and TIMPs were broadly elevated among patients with IPF and are identified as potential MMP/TIMP targets for further development as disease-related biomarkers.